Nephrology Asset Strategy Lead | Launch & Lifecycle

Biogen; Cambridge (MA); Hybrid; USD 204,000 - 281,000; Full time

Benefits offered by this job

Medical, Dental, Vision, & Life ins

Fitness & Wellness programs

Disability insurance

Paid vacation and holidays

401(k) with match

Employee stock purchase plan

Tuition reimbursement

Parental leave

Job summary

Biogen seeks a strategic CMC Asset Lead within the PO&T Nephrology team to oversee asset strategy, launch planning, and lifecycle management for a high-priority nephrology asset slated for 2028–2030 commercialization.

The role requires deep cross-functional leadership across development, commercial, and governance boards, with a track record in global matrix environments and strong financial and risk management capabilities.

Qualifications

• Matrix leadership across program teams and full product lifecycle.
• Experience in commercial launch and alliance management.
• Strong strategic, organizational and relationship development skills.
• Technical expertise in biopharmaceutical development disciplines.

Responsibilities

• Develop and maintain a 5-year PO&T Asset Strategy and an 18-month rolling Tactical Plan.
• Lead the cross-functional Asset Team to deliver on strategic objectives.
• Manage financial accountability, including AOP and FTE allocations, and monitor P&L impacts.
• Develop business cases and secure management endorsement for key initiatives.
• Resolve conflicts related to Asset Strategy with governance boards.
• Represent PO&T on commercial or development teams to influence decisions.
• Collaborate with stakeholders to align asset development with business objectives.
• Oversee asset planning and execution for late-stage activities and launch.
• Conduct scenario planning and lifecycle management evaluations.

Skills

Matrix management

Commercial launch experience

Alliances management

CMC

Supply chain

Life cycle management

Strategic influences

Negotiation

Risk mitigation

Stakeholder management

Cross-functional leadership

Financial accountability

Education

BS or equivalent in Sciences/Engineering

MS/PhD/MBA in a relevant biopharmaceutical discipline

Job description

Biogen seeks a strategic CMC Asset Lead within the PO&T Nephrology team to oversee asset strategy, launch planning, and lifecycle management for a high-priority nephrology asset slated for 2028–2030 commercialization.

The role requires deep cross-functional leadership across development, commercial, and governance boards, with a track record in global matrix environments and strong financial and risk management capabilities.